Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a global pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, surgical drugs, autoimmune diseases, metabolic diseases and cardiovascular diseases. Innovation is the core development strategy. Hengrui has 12 innovative products and 1 cooperative innovative product marketed, more than 60 innovative candidates in the R&D stage, and more than 260 trials under clinical development around the world. Hengrui ranked 24th among the top 1,000 global pharma companies announced by the Torreya in 2021. We have been on the Pharma Exec's annual listing of the top global pharmaceutical companies for the fourth consecutive year, rising from 47th in 2019 to 32nd in 2022.
The order this company entered each market — oldest to newest
Sign up to see the full signal feed
How Hengrui Pharma Co.,Ltd's international expansion compares to its competitors
Hengrui Pharma Co.,LtdYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Hengrui Pharma Co.,LtdYou | 0 | 0 | 0% | 0 | 32 |
Director, Transaction Attorney
View postingShanghai, China · last yr.
Pharmaceutical Ch
View postingJiangsu, China · last yr.
临床管培生--肿瘤医学
View postingShanghai, China · last yr.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
No recent news
Sign up to track this company and get alerted the moment something changes.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Hengrui Pharma Co.,Ltd's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
